Biodexa Pharmaceuticals Plc (BDRX)
1.30
+0.58
(+79.36%)
USD |
NASDAQ |
Apr 26, 16:00
1.21
-0.09
(-6.92%)
After-Hours: 20:00
Biodexa Pharmaceuticals Cash from Operations (TTM): -8.515M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.515M |
| June 30, 2023 | -8.984M |
| December 31, 2022 | -8.575M |
| June 30, 2022 | -8.358M |
| December 31, 2021 | -8.254M |
| June 30, 2021 | -7.264M |
| December 31, 2020 | -11.71M |
| June 30, 2020 | -11.27M |
| December 31, 2019 | -8.346M |
| June 30, 2019 | -13.18M |
| Date | Value |
|---|---|
| December 31, 2018 | -17.90M |
| June 30, 2018 | -14.35M |
| December 31, 2017 | -16.70M |
| June 30, 2017 | -19.19M |
| December 31, 2016 | -17.82M |
| June 30, 2016 | -22.35M |
| December 31, 2015 | -18.92M |
| June 30, 2015 | -13.90M |
| December 31, 2014 | -8.812M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-13.18M
Minimum
Jun 2019
-7.264M
Maximum
Jun 2021
-9.446M
Average
-8.545M
Median
Cash from Operations (TTM) Benchmarks
| Adaptimmune Therapeutics PLC | -140.88M |
| NuCana PLC | -32.90M |
| Autolus Therapeutics PLC | -145.59M |
| Mereo BioPharma Group PLC | -21.13M |
| Bicycle Therapeutics PLC | -60.63M |